Proactive Investors - Run By Investors For Investors

Advanced Oncotherapy maps out plans for growth following £30mln deal with Yantai CIPU

Nicolas Serandour, chief executive of Advanced Oncotherapy PLC (LON:AVO), visited the Proactive Investors studio to add some extra detail to their recent announcement that they've secured £37.4mln of fresh funding - £30mln of this coming from a new Chinese investor.

The injection will bankroll the continuing technical development of the firm’s first LIGHT system and its installation at the Harley Street Proton Therapy Centre.

 
Meet Rockfire Resources PLC, Touchstone Exploration Inc, Mkango Resources Ltd and Salt Lake Potash Ltd at our event, London , 20 June 2019. Register here »
View full AVO profile View Profile

Advanced Oncotherapy PLC Timeline

Article
September 28 2018

© Proactive Investors 2019

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use